Q2 2023 13F Holders as of 6/30/2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
146M
-
Number of holders
-
715
-
Total 13F shares, excl. options
-
94.9M
-
Shares change
-
-582K
-
Total reported value, excl. options
-
$20.7B
-
Value change
-
-$127M
-
Put/Call ratio
-
0.09
-
Number of buys
-
333
-
Number of sells
-
-285
-
Price
-
$218.50
Significant Holders of RESMED INC - Common Stock (RMD) as of Q2 2023
780 filings reported holding RMD - RESMED INC - Common Stock as of Q2 2023.
RESMED INC - Common Stock (RMD) has 715 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 94.9M shares
of 146M outstanding shares and own 64.77% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (17.6M shares), BlackRock Inc. (12.2M shares), STATE STREET CORP (6.39M shares), FMR LLC (6.09M shares), WCM INVESTMENT MANAGEMENT, LLC (3.5M shares), GEODE CAPITAL MANAGEMENT, LLC (3.33M shares), Capital World Investors (2.36M shares), Invesco Ltd. (2.1M shares), CITADEL ADVISORS LLC (1.86M shares), and NORTHERN TRUST CORP (1.62M shares).
This table shows the top 715 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.